Latest on Coronavirus
Applied DNA supplies Covid-19 vaccine candidates for preclinical tests
Applied DNA Sciences has shipped five Covid-19 LinearDNA vaccine candidates to Italy-based Takis Biotech for preclinical testing in animals.
NantKwest and ImmunityBio work on Covid-19 vaccines and drugs
NantKwest and ImmunityBio have partnered to develop potential vaccines and therapeutics against Covid-19. The companies are in discussions with the FDA.
Covid-19 pandemic: the hype around anti-malarial hydroxychloroquine
Central to US President Donald Trump's fight against Covid-19 has been the promotion of hydroxychloroquine. But, can this drug live up to the hype?
Sanofi and GSK partner to develop Covid-19 vaccine
Sanofi and GlaxoSmithKline (GSK) have signed a letter of intent for a partnership focused on developing an adjuvanted vaccine for Covid-19.
AstraZeneca to trial Calquence to treat Covid-19 patients
AstraZeneca is set to conduct a global clinical trial of Calquence (acalabrutinib) to treat cytokine storm that manifests in severely ill Covid-19 patients.
Celltrion identifies antibody candidates against Covid-19
Celltrion Group has completed neutralisation test and identified the antibody candidates that showed the most promise for neutralising SARS-CoV-2.
Immunomic partners EpiVax and PharmaJet on Covid-19 vaccine
Biotechnology firm Immunomic Therapeutics has partnered with EpiVax and PharmaJet to develop a vaccine candidate against Covid-19 infection.
Vir selects Samsung Biologics to produce Covid-19 antibodies
Vir Biotechnology has selected South Korea-based Samsung Biologics for large-scale production of antibodies to potentially treat Covid-19.
Pfizer identifies lead coronavirus drug candidate
Pfizer has announced progress in its research programme to develop antivirals and vaccine for the Covid-19 coronavirus infection.
Australia’s UQ Covid-19 vaccine candidate advances to preclinical tests
The University of Queensland in Australia has progressed its Covid-19 vaccine candidate project into preclinical testing stage.
No comments:
Post a Comment